청소년 다낭성 난소증후군 한약치료에 대한 중의학 임상연구 동향 -무작위 대조군 임상연구를 중심으로-

키워드

참고문헌 (51)

1. Barber TM, "Obesity and polycystic ovary syndrome", Clin Endocrinol(Oxf), 65, pp.137~145 (2006)
2. Rotterdam ESHRE, "ASRM-Sponsored PCOS consensus workshop group", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS), 2004, pp.19(1), 41~47
3. Diamanti-Kandarakis E, "Endocrine-disrupting chemicals : an Endocrine Society scientific statement", Endocr Rev, 30(4), pp.293~342 (2009)
4. Taylor AE, "Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome", J Clin Endocrinol Metab, 82(7), pp.2248~2256 (1997)
5. Unluhizarci K, "Role of insulin and insulin resistance in androgen excess disorders", World J Diabetes, 12(5), pp.616~629 (2021)
6. Cadagan D, "Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome", Reprod Biol, 16(1), pp.53~60 (2016)
7. Danielson KK, "Sex hormonebinding globulin and testosterone in individuals with childhood diabetes", Diabetes Care, 31(6), pp.1207~1213 (2008)
8. Sekhon AK, "The Association between polycystic ovary syndrome and its dermatological manifestations", Cureus, 12(2), pp.e6855~ (2020)[DOI]
9. Wondmkun YT, "Obesity, insulin resistance, and type 2 diabetes : associations and therapeutic implications", Diabetes Metab Syndr Obes, 13, pp.3611~3616 (2020)
10. Azziz R, "Androgen excess in women : experience with over 1000 consecutive patients", J Clin Endocrinol Metab, 89(2), pp.453~462 (2004)
11. Arroyo A, "Inappropriate gonadotropin secretion in polycystic ovary syndrome : influence of adiposity", J Clin Endocrinol Metab, 82(11), pp.3728~3723 (1997)
12. Franks S, "Polycystic ovary syndrome in adolescents", Int J Obes(Lond), 32(7), pp.1035~1041 (2008)
13. Anderson AD, "Childhood obesity and its impact on the development of adolescent PCOS", Semin Reprod Med, 32(3), pp.202~213 (2014)
14. Naz MSG, "The prevalence of polycystic ovary syndrome in adolescents : A systematic review and meta-analysis", Int J Reprod Biomed, 17(8), pp.533~542 (2019)
15. Blank SK, "The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome", Hum Reprod Update, 12(4), pp.351~361 (2006)
16. Legro RS, "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome : a prospective, controlled study in 254affected women", J Clin Endocrinol Metab, 84(1), pp.165~169 (1999)
17. Legro RS, "Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome", Am J Med, 111(8), pp.607~613 (2001)
18. Gutierrez-Grobe Y, "Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens", Ann Hepatol, 9(4), pp.402~409 (2010)
19. Elting MW, "Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population", Hum Reprod, 16(3), pp.556~560 (2001)
20. Pfeifer SM, "Polycystic ovary syndrome in the adolescent", Obstet Gynecol Clin North Am, 36(1), pp.129~152 (2009)
21. Kim DI, "A bibliographical study on polycystic ovarian syndrome", J Korean Obstet Gynecol, 10(1), pp.73~91 (1997)
22. Cho YJ, "A review of the clinical study trends on Korean medicine treatment for polycystic ovary syndrome", J Korean Obstet Gynecol, 35(2), pp.87~105 (2022)
23. Won AN, "A review on clinical studies of herbal treatment for infertility caused by polycystic ovary syndrome-focusing on Chinese clinical trials-", J Korean Obstet Gynecol, 27(4), pp.43~56 (2014)
24. Yoon JG, "Electroacupuncture for treatment of polycystic ovarian syndrome : systematic review of randomized controlled trials", J Korean Obstet Gynecol, 31(4), pp.39~53 (2018)
25. Kim SH, "Recent acupuncture therapy for polycystic ovary syndromes : systematic review", J Korean Obstet Gynecol, 27(2), pp.71~82 (2014)
26. Li L, "Clinical research on kidney-tonifying and blood-activating therapy for the treatment of puberty polycystic ovarian syndrome", J Guangzhou University Tradit Chin Med, 26(03), pp.221~224 (2009)
27. Zheng YX, "Clinical review on treatment of adolescent polycystic ovary syndrome using gagamjeongkyeongtang", J New Chin Med, 44(4), pp.63~65 (2012)
28. Zhong DD, "Effects of Bushen Huoxue decoction on endocrine hormones in adolescent polycystic ovarian syndrome", J Practical Tradit Chin Med, 32(6), pp.522~523 (2016)
29. Zhang Y, "Long-term effects of liver-smoothing and heat-clearing decoction on the treatment of polycystic ovarian syndrome with heat stagnated in liver meridian type in adolescence", Hebei J Tradit Chin Med, 38(9), pp.1305~1312 (2016)
30. Zhang YH, "Clinical effect of replenishing qi and nourishing blood on adolescent polycystic ovary syndrome", J Zunyi Med University, 40(2), pp.196~199 (2017)
31. Chen JJ, "Clinical study of Yishen Qutan decoction in the treatment of adolescent PCOS of intermingled phlegm and blood stasis", Inf Tradit Chin Med, 37(1), pp.67~71 (2020)
32. Lu Y, "Clinical study on the treatment of adolescent patients with polycystic ovary syndrome by periodic medication with kidney-tonifying and blood-activating", Chinese J Human Sexuality, 29(12), pp.103~106 (2020)
33. Thompson IR, "GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression", Mol Cell Endocrinol, 385(1-2), pp.28~35 (2014)
34. Dunaif A, "Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome", Diabetes, 38(9), pp.1165~1174 (1989)
35. Ramezani Tehrani F, "Polycystic Ovary Syndrome in Adolescents : Challenges in Diagnosis and Treatment", Int J Endocrinol Metab, 17(3), pp.e91554~ (2019)
36. Escobar-Morreale HF, "Polycystic ovary syndrome : definition, aetiology, diagnosis and treatment", Nat Rev Endocrinol, 14(5), pp.270~284 (2018)
37. Escobar-Morreale HF, "Epidemiology, diagnosis and management of hirsutism : a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society", Hum Reprod Update, 18(2), pp.146~170 (2012)
38. Amiri M, "Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome : a systematic review and meta-analysis", Eur J Contracept Reprod Health Care, 23(1), pp.64~77 (2018)
39. Vandenbroucke JP, "Oral contraceptives and the risk of venous thrombosis", N Engl J Med, 344(20), pp.1527~1535 (2001)
40. Diamanti-Kandarakis E, "Metformin : an old medication of new fashion : evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome", Eur J Endocrinol, 162(2), pp.193~212 (2010)
41. Hoeger K, "The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials", J Clin Endocrinol Metab, 93(11), pp.4299~4306 (2008)
42. Abazar E, "Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome", Adv Biomed Res, 4, pp.68~ (2015)
43. Legro RS, "Diagnosis and treatment of polycystic ovary syndrome : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 98(12), pp.4565~4592 (2013)
44. National Korean Medicine University Herbology Joint Textbook Compilation Committee, "Bonchohak", pp.450~623 (2014), Young Lim Publishing Co
45. Sze SC, "Herba Epimedii : anti-oxidative properties and its medical implications", Molecules, 15(11), pp.7861~7870 (2010)
46. Agarwal A, "Role of reactive oxygen species in the pathophysiology of human reproduction", Fertil Steril, 79(4), pp.829~843 (2003)
47. Oh TW, "Anti-diabetic effect of medicinal plants used for lower wasting-thirst in streptozotocin-induced diabetic rats", Kor J Herbology, 28(5), pp.53~60 (2013)
48. Kang HK, "Peripubertal administration of icariin and icaritin advances pubertal development in female rats", Biomol Ther(Seoul), 20(2), pp.189~195 (2012)
49. Kim HW, "Effects of Angelicae Gigantis Radix(AGR)on polycystic ovary induced by estradiol valerate in rats", Kor J Herbology, 26(1), pp.81~85 (2011)
50. Hickey M, "Abnormal uterine bleeding : a focus on polycystic ovary syndrome", Women’s Health, 5(3), pp.313~324 (2009)
51. Kim MK, "Analysis of herbal-drug-associated adverse drug reactions using data from spontaneous reporting system in electronic medical records", J Korean Med, 36(1), pp.45~60 (2015)

관련 논문AI추천